Bacillus Calmette-Guerin in Immunosuppressed Patient with High-Grade Nonmuscle Invasive Bladder Carcinoma

被引：6

作者：

Aznar Martinez, Laura ^{[1
]}

Lopez Cubillana, Pedro ^{[1
]}

Lopez Abadb, Alicia ^{[2
]}

Vidal Crespo, Natalia ^{[1
]}

Gomez Gomez, Guillermo Antonio ^{[1
]}

机构：

[1] Virgen de la Arrixaca Clin Univ Hosp, Dept Urol, Enrique Gallego 17, ES-30120 Murcia, Spain

[2] Univ Murcia, Dept Urol, Murcia, Spain

来源：

UROLOGIA INTERNATIONALIS | 2019年 / 103卷 / 02期

关键词：

Nonmuscle invasive bladder cancer; Immunosuppressed; Kidney transplant; Treatment; RENAL-TRANSPLANT RECIPIENTS; TRANSITIONAL-CELL CARCINOMA; CANCER;

D O I：

10.1159/000501108

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Due to their immunosuppressed status, solid organ transplant recipients are a special group of patients with an incidence of bladder cancer greater than the rest of the population, especially in the first 6 years after transplantation. Also, treatment with Bacillus Calmette-Guerin, a reference therapy in nonmuscle invasive high-risk bladder cancer, may be less effective in this group of patients and could cause more adverse effects. However, the data published so far and the experience initiated in the Virgen de la Arrixaca Clinical University Hospital do not support these hypotheses. (C) 2019 S. Karger AG, Basel

引用

页码：242 / 244

页数：3

共 11 条

[1] EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Babjuk, Marko
Boehle, Andreas
Burger, Maximilian
Capoun, Otakar
Cohen, Daniel
Comperat, Eva M.
Hernandez, Virginia
Kaasinen, Eero
Palou, Joan
Roupret, Morgan
van Rhijn, Bas W. G.
Shariat, Shahrokh F.
Soukup, Viktor
Sylvester, Richard J.
Zigeuner, Richard
[J]. EUROPEAN UROLOGY, 2017, 71 (03) : 447 - 461
[2] Intravesical Bacille Calmette-Guerin in immunosuppressed patient with carcinoma in situ
Bonarriba, Carlo R.
de La Cruz-Ruiz, Marta
Gomez-Marques, Gonzalo
[J]. NEFROLOGIA, 2013, 33 (03): : 429 - 431
[3] Bladder cancer in renal transplant recipients
Buzzeo, BD
Heisey, DM
Messing, EM
[J]. UROLOGY, 1997, 50 (04) : 525 - 528
[4] Bladder carcinoma among live-donor renal transplant recipients: a single-centre experience and a review of the literature
Kamal, Mohamed M.
Soliman, Shady M.
Shokeir, Ahmed A.
Abol-Enein, Hassan
Ghoneim, Mohamed A.
[J]. BJU INTERNATIONAL, 2008, 101 (01) : 30 - 35
[5] Manzanilla-Garcia HA, 2009, REV MEX UROL, V69, P307
[6] De Novo Bladder Urothelial Neoplasm in Renal Transplant Recipients: A Retrospective, Multicentered Study
Palazzetti, Anna
Bosio, Andrea
Dalmasso, Ettore
Destefanis, Paolo
Fop, Fabrizio
Pisano, Francesca
Segoloni, Giuseppe
Biancone, Luigi
Volpe, Alessandro
Di Domenico, Antonia
Terrone, Carlo
Iesari, Samuele
Famulari, Antonio
Todeschini, Paola
Frea, Bruno
Gontero, Paolo
[J]. UROLOGIA INTERNATIONALIS, 2018, 100 (02) : 185 - 192
[7] Intravesical bacillus Calmette-Gurrin for the treatment of superficial bladder cancer in renal transplant patients
Palou, J
Angerri, O
Segarra, J
Caparrós, J
Guirado, L
Diaz, JM
Salvador-Bayarri, J
Villavicencio-Mavrich, H
[J]. TRANSPLANTATION, 2003, 76 (10) : 1514 - 1516
[8] T1G3 transitional cell carcinoma of the bladder: recurrence, progression and survival
Peyromaure, M
Zerbib, M
[J]. BJU INTERNATIONAL, 2004, 93 (01) : 60 - 63
[9] Management of Bladder Cancer following Solid Organ Transplantation
Tomaszewski, Jeffrey J.
Larson, Jeffrey A.
Smaldone, Marc C.
Hayn, Matthew H.
Jackman, Stephen V.
[J]. ADVANCES IN UROLOGY, 2011, 2011
[10] Vegt PDJ, 1997, J UROLOGY, V157, P1246, DOI 10.1016/S0022-5347(01)64936-X

← 1 2 →